About CathVision
CathVision is a company based in Copenhagen (Denmark) founded in 2013 by Rune Orndrup. CathVision has raised $36.08 million across 11 funding rounds from investors including European Union, EIC Fund and Danmarks Eksport- og Investeringsfond. The company has 21 employees as of November 30, 2024. CathVision offers products and services including ECGenius System and CARDIALYTICS. CathVision operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
- Headquarter Copenhagen, Denmark
- Employees 21 as on 30 Nov, 2024
- Founders Rune Orndrup
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cathvision Aps
-
Annual Revenue
Not available
-
Net Profit
-$1 M (USD)-38as on Dec 31, 2021
-
EBITDA
-$1.47 M (USD)-28as on Dec 31, 2021
-
Total Equity Funding
$36.08 M (USD)
in 11 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jul 18, 2023
-
Investors
European Union
& 3 more
-
Employee Count
21
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CathVision
CathVision offers a comprehensive portfolio of products and services, including ECGenius System and CARDIALYTICS.
Enhances cardiac electrical signals for improved arrhythmia diagnosis.
Offers automated tools for analyzing atrial fibrillation and other arrhythmias.
People of CathVision
Unlock access to complete
Unlock access to complete
Funding Insights of CathVision
CathVision has successfully raised a total of $36.08M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CathVision
CathVision has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Danmarks Eksport- og Investeringsfond.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Provision of financing, loans, equity, and insurance for Danish export and investment activities.
|
Locked | Locked | Locked | |
|
Borean is engaged in providing outdoor adventure experiences.
|
Locked | Locked | Locked |
Investor details for CathVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CathVision
Investment portfolio details for CathVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CathVision
Detailed financials for CathVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cathvision Comparisons
Peer comparison for CathVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CathVision
CathVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of CathVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cathvision
Complete news archive for CathVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CathVision
CathVision was founded in 2013 and raised its 1st funding round 1 year after it was founded.
CathVision is headquartered in Copenhagen, Denmark.
CathVision is a funded company, having raised a total of $36.08M across 11 funding rounds to date.
As of Nov 30, 2024, the latest employee count at CathVision is 21.
CathVision was founded in 2013 in Copenhagen, Denmark, as a developer of AI-based software and devices for cardiac electrophysiology in the medical technology sector. The CathVision Cube is provided to visualize electrophysiology signals, enabling accurate therapy delivery through low-noise ablation and high signal quality. Real-time streaming, analysis, and storage of EP signals are supported, with AI algorithms integrated into the interface for clinical decision support.
CathVision's top competitors include AtaCor Medical, AtriCure and CardioFocus.
CathVision offers ECGenius System and CARDIALYTICS.
CathVision has 4 investors. Key investors include European Union, EIC Fund, Danmarks Eksport- og Investeringsfond, and Borean.
The valuation of CathVision is $28.42M as of May 2022.